>
pdufa.bio

buntanetap/posiphen

Updated ยทnext FDA decision on the calendar

buntanetap/posiphen is a Annovis Bio, Inc. program. Its next catalyst is a Readout in Dec 2027. Every date links its source.

ANVS catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Annovis Bio, Inc. (ANVS). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Dec 2027ANVS

Questions

When is buntanetap/posiphen's next FDA decision or readout?

The next tracked catalyst for buntanetap/posiphen is a Readout in Dec 2027.

What happened at buntanetap/posiphen's most recent FDA decision?

No FDA decision for buntanetap/posiphen is in our archive yet.

Who makes buntanetap/posiphen?

Annovis Bio, Inc. (ANVS).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.